The cardiovascular manifestations of systemic sclerosis (scleroderma)
- 1 May 1986
- journal article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 11 (5) , 244-298
- https://doi.org/10.1016/0146-2806(86)90022-8
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- Effects of beta-adrenoreceptor-blocking drugs in patients with Raynaud's phenomenon.Circulation, 1985
- Physiologic Abnormalities of Cardiac Function in Progressive Systemic Sclerosis with Diffuse SclerodermaNew England Journal of Medicine, 1984
- Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's PhenomenonNew England Journal of Medicine, 1983
- Control of Hypertension and Reversal of Renal Failure in SclerodermaNew England Journal of Medicine, 1978
- Cryoablation of drug-resistant ventricular tachycardia in a patient with a variant of scleroderma.Circulation, 1978
- Esophageal dysfunction and Raynaud's phenomenon in patients with sclerodermaDigestive Diseases and Sciences, 1976
- Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.Circulation, 1976
- De Subitaneis MortibusCirculation, 1974
- Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic SclerodermaCirculation, 1960
- Electrocardiograms of Ninety Patients with Acrosclerosis and Progressive Diffuse Sclerosis (Scleroderma)Circulation, 1958